Psychedelics in Oral and Maxillofacial Surgery

Psychedelics in Oral and Maxillofacial Surgery

In recent years, there has been a growing interest in the use of psychedelic substances as a potential treatment option for a variety of medical conditions. Regulatory restrictions on research into psychedelics were lifted in 2000, and the first landmark study on psilocybin at Johns Hopkins University was published in 2006. The volume of research has been growing every year. Psychedelics such as psilocybin, lysergic acid diethylamide (LSD) and methylenedioxymethamphetamine (MDMA) have been shown in clinical trials to be effective in treating conditions such as depression, anxiety, PTSD, addiction and end-of-life distress. In recent years, several cities such as Detroit, Seattle and Santa Cruz as well as all of Oregon and Colorado have decriminalized the possession and use of psychedelic substances. The FDA has granted breakthrough therapy designation for psilocybin and MDMA-assisted therapy for certain conditions. As legislation changes and psychedelics move from the underground to the mainstream, the anesthetic, dental and oral and maxillofacial surgery fields will have to adjust. This 60-minute webinar will define psychedelics and explore the risks, benefits and potential place in dentistry and oral and maxillofacial surgery.

Learning Objectives

At the conclusion of this program, participants should be able to:

1. Identify the most common types of psychedelics used by patients.  
2. Describe non-ordinary states of consciousness. 
3. Analyze the potential of psychedelics for anxiety management. 
4. Apply knowledge of psychedelics into clinical practice with regard to surgery and anesthesia.

Cancellation Policy: Registrants will receive a full refund up until the day before the event. No refund will be given on the day of or after the event. 

Register for the two-part Clinical Webinar Series on Anesthesia and Medicine and save $50 off the original price of $250!

Continuing Education Provider Approval
The American Association of Oral and Maxillofacial Surgeons is an ADA CERP Recognized Provider.

ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education.

ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.

The American Association of Oral and Maxillofacial Surgeons designates this activity for 1.0 continuing education credit(s).

AGD - Accepted Program Provider
FAGD/MAGD Credit
11/1/22-12/31/26
Provider ID# 214680

The American Association of Oral and Maxillofacial Surgeons (AAOMS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Association of Oral and Maxillofacial Surgeons designates this internet-based live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.